Block on Trump's Asylum Ban Upheld by Supreme Court
The U.S. Food and Drug Administration (FDA) has ordered manufacturers of certain prescription sleep aids, including Ambien, to strengthen their product labeling to include stronger language concerning potential risks -- including the risk of "sleep-driving" episodes. According to the FDA, "sleep driving" is defined as driving while not fully awake after taking sleep aid medication, with no memory of the event.
Sign into your Legal Forms and Services account to manage your estate planning documents.Sign In
Create an account allows to take advantage of these benefits: